Literature DB >> 33678425

Voluntary wheel running with and without follistatin overexpression improves NMJ transmission but not motor unit loss in late life of C57BL/6J mice.

Deepti Chugh1, Chitra C Iyer1, Prameela Bobbili1, Anton J Blatnik2, Brian K Kaspar3, Kathrin Meyer4, Arthur Hm Burghes2, Brian C Clark5, W David Arnold6.   

Abstract

Sarcopenia, or pathological loss of muscle mass and strength during aging, is an important contributor to loss of physical function in older adults. Sarcopenia is a multifactorial syndrome associated with intrinsic muscle and upstream neurological dysfunction. Exercise is well-established as an effective intervention for sarcopenia, but less is known about the long-term neurobiological impact of exercise. The goals of this study were to investigate the effects of exercise, alone or in combination with follistatin (FST) overexpression (antagonist of myostatin), on neuromuscular junction transmission and motor unit numbers in mice between the age of 22 and 27 months, ages at which prior studies have demonstrated that some motor unit loss is already evident. C57BL/6J mice underwent baseline assessment and were randomized to housing with or without voluntary running wheels and injection with adeno-associated virus to overexpress FST or vehicle. Groups for comparison included sedentary and running with and without FST. Longitudinal assessments showed significantly increased muscle mass and contractility in the 'running plus FST' group, but running, with and without FST, showed no effect on motor unit degeneration. In contrast, running, with and without FST, demonstrated marked improvement of neuromuscular junction transmission stability.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Aging; Exercise; Follistatin; Motor Unit; Neuromuscular Junction

Mesh:

Substances:

Year:  2021        PMID: 33678425      PMCID: PMC8122043          DOI: 10.1016/j.neurobiolaging.2021.01.012

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  61 in total

1.  Fidelity of muscle fibre reinnervation modulates ageing muscle impact in elderly women.

Authors:  Vita Sonjak; Kathryn Jacob; José A Morais; Marie Rivera-Zengotita; Sally Spendiff; Carole Spake; Tanja Taivassalo; Stéphanie Chevalier; Russell T Hepple
Journal:  J Physiol       Date:  2019-08-21       Impact factor: 5.182

Review 2.  Role of exercise in maintaining the integrity of the neuromuscular junction.

Authors:  Hiroshi Nishimune; John A Stanford; Yasuo Mori
Journal:  Muscle Nerve       Date:  2013-12-17       Impact factor: 3.217

3.  Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise.

Authors:  Gregorio Valdez; Juan C Tapia; Hyuno Kang; Gregory D Clemenson; F H Gage; Jeff W Lichtman; Joshua R Sanes
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

4.  A method for estimating the number of motor units in thenar muscles and the changes in motor unit count with ageing.

Authors:  W F Brown
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-12       Impact factor: 10.154

5.  Target-derived trophic effect on skeletal muscle innervation in senescent mice.

Authors:  Maria Laura Messi; Osvaldo Delbono
Journal:  J Neurosci       Date:  2003-02-15       Impact factor: 6.167

Review 6.  Men and mice: Relating their ages.

Authors:  Sulagna Dutta; Pallav Sengupta
Journal:  Life Sci       Date:  2015-10-24       Impact factor: 5.037

7.  Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium.

Authors:  Shalender Bhasin; Thomas G Travison; Todd M Manini; Sheena Patel; Karol M Pencina; Roger A Fielding; Jay M Magaziner; Anne B Newman; Douglas P Kiel; Cyrus Cooper; Jack M Guralnik; Jane A Cauley; Hidenori Arai; Brian C Clark; Francesco Landi; Laura A Schaap; Suzette L Pereira; Daniel Rooks; Jean Woo; Linda J Woodhouse; Ellen Binder; Todd Brown; Michelle Shardell; Quian-Li Xue; Ralph B DʼAgostino; Denise Orwig; Greg Gorsicki; Rosaly Correa-De-Araujo; Peggy M Cawthon
Journal:  J Am Geriatr Soc       Date:  2020-03-09       Impact factor: 5.562

8.  Motor unit number estimates and neuromuscular transmission in the tibialis anterior of master athletes: evidence that athletic older people are not spared from age-related motor unit remodeling.

Authors:  Mathew Piasecki; Alex Ireland; Jessica Coulson; Dan W Stashuk; Andrew Hamilton-Wright; Agnieszka Swiecicka; Martin K Rutter; Jamie S McPhee; David A Jones
Journal:  Physiol Rep       Date:  2016-10

9.  Identifying Characteristics of Frailty in Female Mice Using a Phenotype Assessment Tool.

Authors:  Dongmin Kwak; Cory W Baumann; LaDora V Thompson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-03-09       Impact factor: 6.053

10.  Sex differences in body composition but not neuromuscular function following long-term, doxycycline-induced reduction in circulating levels of myostatin in mice.

Authors:  Dallin Tavoian; W David Arnold; Sophia C Mort; Sonsoles de Lacalle
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240

View more
  3 in total

1.  Profiling age-related muscle weakness and wasting: neuromuscular junction transmission as a driver of age-related physical decline.

Authors:  Carlos J Padilla; Markus E Harrigan; Hallie Harris; Jan M Schwab; Seward B Rutkove; Mark M Rich; Brian C Clark; W David Arnold
Journal:  Geroscience       Date:  2021-04-24       Impact factor: 7.713

2.  Follistatin-induced muscle hypertrophy in aged mice improves neuromuscular junction innervation and function.

Authors:  Chitra C Iyer; Deepti Chugh; Prameela J Bobbili; Anton J Blatnik Iii; Alexander E Crum; Allen F Yi; Brian K Kaspar; Kathrin C Meyer; Arthur H M Burghes; W David Arnold
Journal:  Neurobiol Aging       Date:  2021-03-12       Impact factor: 5.133

3.  Ageing and exercise-induced motor unit remodelling.

Authors:  Eleanor J Jones; Shin-Yi Chiou; Philip J Atherton; Bethan E Phillips; Mathew Piasecki
Journal:  J Physiol       Date:  2022-03-29       Impact factor: 6.228

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.